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Mendelian inheritance of trimodal CpG
methylation sites suggests distal cis-acting
genetic effects
Shaza B. Zaghlool1,2, Mashael Al-Shafai3,4,8, Wadha A. Al Muftah3,4, Pankaj Kumar1, Christian Gieger6,7,
Melanie Waldenberger6,7, Mario Falchi5 and Karsten Suhre1*
Abstract
Background: Environmentally influenced phenotypes, such as obesity and insulin resistance, can be transmitted
over multiple generations. Epigenetic modifications, such as methylation of DNA cytosine-guanine (CpG) pairs, may
be carriers of inherited information. At the population level, the methylation state of such “heritable” CpG sites is
expected to follow a trimodal distribution, and their mode of inheritance should be Mendelian.
Methods: Using the Illumina Infinium 450 K DNA methylation array, we determined DNA CpG-methylation in blood
cells from a family cohort 123 individuals of Arab ethnicity, including 18 elementary father-mother-child trios, we asked
whether Mendelian inheritance of CpG methylation is observed, and most importantly, whether it is independent of
any genetic signals. Using 40× whole genome sequencing, we therefore excluded all CpG sites with possibly
confounding genetic variants (SNP) within the binding regions of the Illumina probes.
Results: We identified a total of 955 CpG sites that displayed a trimodal distribution and confirmed trimodality in
a study of 1805 unrelated Caucasians. Of 955 CpG sites, 99.9% observed a strict Mendelian pattern of inheritance
and had no SNP within +/−110 nucleotides of the CpG site by design. However, in 97% of these cases a distal
cis-acting SNP within a +/−1 Mbp window was found that explained the observed CpG distribution, excluding
the hypothesis of epigenetic inheritance for these clear-cut trimodal sites. Using power analysis, we showed that
in 46% of all cases, the closest CpG-associated SNP was located more than 1000 bp from the CpG site.
Conclusions: Our findings suggest that CpG methylation is maintained over larger genomic distances. Furthermore,
nearly half of the SNPs associated with these trimodal sites were also associated with the expression of nearby genes
(P = 4.08 × 10−6), implying a regulatory effect of these trimodal CpG sites.
Keywords: Mendelian inheritance, DNA methylation, Epigenetics, CpG, Trimodal distribution, Genetic variance
Background
Environmental factors can affect phenotype in a herit-
able manner without altering the DNA sequence [1], as
evidenced by studies of environmental stresses such as
exposure to chemicals, dietary intake, and temperature
changes, among others [2–4]. Epigenetic changes, such as
cytosine methylation in the context of cytosine-guanine
(CpG) dinucleotides are hypothesized to occur in response
to environmental challenges that indirectly affect
phenotype through changes in gene expression [2, 5–8].
DNA methylation is one of the most commonly studied
forms of epigenetic modification [9]. However, there is
presently a gap in understanding how epigenetic marks
are passed from generation to generation, and how inher-
ited DNA methylation is re-established after meiosis.
A number of studies suggested that although methyla-
tion occurs in response to environmental changes, these
epigenetic modifications can actually be inherited [10].
More recently, epigenetic heritable changes in traits
such as flowering time and root length were reported
in different strains of Arabidopsis [11, 12]. Stable in-
heritance of several epigenetic alterations that
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contribute to these complex heritable traits can propa-
gate for more than eight generations in the absence of
extensive DNA sequence polymorphisms, suggesting
that the effect of loss or gain of DNA methylation can
indeed be transmitted across generations [11, 12].
Trans-generational epigenetic inheritance has also been
reported in animals and has been initially inspired by
observations in families from the Dutch famine of
1944, where starvation in one generation led to altered
body composition and poorer health in the grandchil-
dren [13]. Moreover, diet-induced obesity in male mice
led to widespread changes in DNA methylation and
caused diabetes and insulin resistance in their offspring
[14]. Furthermore, pregnant mice on a near-starvation
diet were reported to have offspring that were signifi-
cantly smaller than normal, and even though these
young were well fed, their own offspring were also born
unusually small and with a higher risk of diabetes [15].
In another study [16], the hereditary transmission of
environmental information in the form of parental
traumatic exposure was also reported to trace back to
epigenetics.
Here we ask whether CpG methylation patterns that
follow Mendelian inheritance can be observed in a human
population. Methylation of a single CpG site in a given
cell corresponds to a binary mark (either methylated or
unmethylated). Because each cell has two copies of each
chromosome, methods that determine CpG methylation
generally distinguish between a methylated, hemi-
methylated, or unmethylated state for a specific CpG
site. Moreover, most methylation measurements are
performed on an ensemble of cells, potentially includ-
ing different cell types. Thus, the numeric value of the
methylation state of a given CpG site represents the
percentage of individual CpG dinucleotides that are
methylated in any given sample, often referred to as
the β value or beta [17]. In the most clear-cut situ-
ation, one would expect a trimodal distribution of the
degree of methylation of a single inherited CpG site
on a population scale: individuals who inherited two
unmethylated CpG alleles would be expected to dis-
play low or zero overall CpG methylation (β value~0),
individuals who inherited one unmethylated and one
methylated CpG allele would show a hemi-methylated
signal (β value~0.5), and individuals who inherited two
methylated CpG alleles would show a fully methylated sig-
nal (β value~1).
Using the Illumina Infinium 450 K DNA methylation
array to determine DNA CpG-methylation on a gen-
ome-wide scale in white blood cells from two previ-
ously published studies, a family cohort of 123
individuals of Arab ethnicity [18] [19], and from 1805
unrelated individuals of Caucasian descent, [20] we first
identify all CpG sites that display a trimodal
distribution in both cohorts. Using 40× whole genome
sequencing performed in the Arab cohort, we then ex-
clude all CpG sites that contain genetic variants in the
vicinity of that site to eliminate cases that may corres-
pond to a deletion of the CpG site itself or that lie in the
binding regions of the Illumina probes [21]. Finally, we
test the trimodal sites for Mendelian inheritance using a
total of 18 nuclear father-mother-child trios in the Arab
cohort.
Methods
Study population
A total of 123 Qatari study participants, including 72
women (mean age 39 ± 16.9 years) and 51 men (mean age
36.3 ± 17.2 years) were included. This study population
has been used and described in previous work [18, 19].
Briefly, the dataset consisted of 15 families with a variety
of complex pedigree structures. Seven families contained
trios with one to four offspring per family, resulting in
a total of 18 trios available for analysis. This study was
approved by the Institutional Review Board of Weill
Cornell Medical College in Qatar in concordance with
the Helsinki declaration of ethical principles for medical
research involving human subjects (ethical approval num-
ber 2012-003 and 2012-0025). Participants provided writ-
ten informed consent.
Methylation
A total of 7 ml of venous peripheral blood was drawn
from all participants and collected in EDTA anti-
coagulant tubes. Genomic DNA extraction was per-
formed in the WCMC-Q clinical laboratory with 2 ml
of fresh whole blood following Qiagen protocols using
the QIAamp Blood Midi Kit (Qiagen, spin protocol)
catalog number (51183). Genomic DNA was quanti-
fied using the Qubit 2.0 fluorometer from Invitrogen
(Qubit dsDNA BR Assay Kit; catalog numbers
Q32850, Q32853). Genome-wide DNA methylation
profiling was performed using the Illumina Infinium
HumanMethylation450 (450 K) BeadChip array [22]
for interrogating over 485,000 methylation sites per
sample. The HumanMethylation450 platform uses
genotyping sodium bisulphate–treated DNA at a sin-
gle base resolution and incorporates two assays, Infi-
nium I and Infinium II. Infinium I uses two 50-bp
probes with a single color channel for both methyl-
ated and unmethylated CpG sites with the assumption
that all methylated CpG sites match the targeted sites.
Infinium II uses a single probe at each site with two
different color channels (green and red) for the detec-
tion of methylated and unmethylated CpG sites. In
total, we obtained methylation data for 485,577 sites.
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Whole genome sequencing
We obtained whole genome sequencing data from Illumina
using the Hiseq 2500 platform for 93 subjects. The average
depth of coverage that was used to obtain paired end
sequence reads was 40×. We obtained variant sets by
processing the sequences with the CASAVA version 1.9
pipeline (Consensus Assessment of Sequence And
VAriation), which is a proprietary bioinformatics Illu-
mina pipeline. The CASAVA pipeline includes align-
ment of the reads to the reference genome, sorting,
indexing, realigning, and variant calling. Paired end
reads were aligned to the reference human genome of
NCBI build 37 using the aligner ELNAD v2 (Efficient
Large-Scale Alignment of Nucleotide Database) in the
CASAVA pipeline. Variant calling uses a probabilistic
algorithm to call the genomic consensus sequence and
compares it to the reference sequence to identify
homozygous or heterozygous SNPs. For each of the
variants called, CASAVA also provides quality mea-
sures. We filtered the SNPs based on the quality score
provided to retain variants with an error probability
less than 0.01. In total, we obtained 14,595,042 genetic
variants, called in at least one individual at a quality
cutoff of q20.
Normalization and quality control
Quality control was performed on the methylation data
(485,577 CpG sites) from the Qatari sample. These steps
included confirmation checks to ensure sample integrity,
initial filtering of the 65 SNPs from Illumina manifest
and 3091 CpHs, and checking that the percentage of de-
tected sites was over 99.5% (with a P value <0.01). Using
the whole genome sequencing data, we also verified
Mendelian inheritance in the trios. The average accept-
able percentage of whole genome sequencing Mendelian
violations did not exceed 10% for all trios. The overall
signal intensity and the distribution of β values of the
samples were then inspected for any abnormalities. No
samples were excluded due to low signal intensity or
having abnormal methylation profiles. After all of the fil-
tering, a total of 482,421 methylation sites remained
under consideration. Genetic variants or SNPs in probes
or CpG sites can interfere with methylation readouts by
affecting probe binding. Therefore, based on the whole
genome sequencing data, all methylation data were set
to missing values whenever a genetic variant existed
within the probe-binding region of ±110 base pairs of
the CpG. Incorporating the whole genome sequencing
data ensured that no local SNPs were affecting the
methylation. These accounted for about 0.5% of the
methylation sites that were replaced by missing values.
The data were also color bias adjusted, quantile normal-
ized, and BMIQ normalized using the LUMI + BMIQ
pipeline [23, 24].
KORA population study
Data from 1805 subjects of the previously published
KORA cohort were used. KORA is a study of a general
population living in southern Germany, as described in
Ref [20]. In brief, these subjects were unrelated individ-
uals with a mean age of 60.9 ± 8.9, with 925 women and
880 men. Array-based DNA methylation data (Infinium
HumanMethylation 450 BeadChip platform [22]) was
obtained for these subjects. A total of 1000 ng of genomic
DNA was bisulphate-converted using the EZ-96 DNA
Methylation Kit (Zymo Research, Orange, CA, USA)
following the manufacturer’s protocol. All samples were
preprocessed using Genome Studio for background
subtraction and control normalization. A total of 457,004
CpG sites were used for the analysis of this study. Various
quality checks were performed on these data and have
been described in studies in which they were previously
used [25–27].
Definition of trimodality and Mendelian inheritance
agreement/violation
A “trimodal site” is defined here as a CpG site that had
at least one individual falling into each of three prede-
fined methylation states (methylated, hemi-methylated,
and unmethylated) and in addition to at least 95% of the
subjects falling inside the defined regions. The methyla-
tion states are defined as follows:
Full methylated 0.8 < β ≤ 1
Hemi-methylated 0.35 ≤ β ≤ 0.65
Unmethylated 0 ≤ β < 0.2
We required trimodality to occur in both populations
so that only CpGs that were trimodal in both studies
were retained for further analysis. Mendelian agreements
and violations for the methylation states were then iden-
tified. For instance, if the parents were both fully meth-
ylated (homozygous) for a given CpG, then the offspring
would also have to be fully methylated to conform to
Mendelian inheritance.
Testing for SNP-methylation association in the Qatari sample
The Qatari sample DNA was sequenced by Illumina for
93 of the 123 subjects. The trimodal sites were checked
for SNP-methylation associations only for those subjects
for which both, methylation and sequencing data, were
available. The window size was set to ±1 Mbp around
each trimodal CpG locus. Contingency tables were gen-
erated for each methylation site against each SNP from
the sequencing data in a specified window, considering
all subjects (three rows for the three methylation states,
and three columns for the three allelic states). The chi-
square test of independence for count data was used to
test for associations between the methylation state and
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genotype. P values were computed for every trimodal
methylation site, for all SNPs in the same window. Be-
cause of the limited number of samples, the minimum
obtainable P value was 0.0005, which made the detect-
ability of significant associations heavily dependent on
the window size (the larger the window, the greater the
number of SNPs contained in that window, which is the
denominator in the P value cutoff). The strongest associa-
tions occurred when the three methylation states segre-
gated perfectly with the respective genotypes. A Bonferroni
cutoff of significance for the P values was used where the
significance for a given window size and a particular site
was computed as follows:
P value ¼ 0:05
Actual number of SNPs in that window
To compute the power of the chi-squared test, the
“pwr.chisq.test” function in the R library “pwr” was used
[28]. First, the effect size w for two sets of k probabilities,
P0 (null hypothesis), and P1 (alternative hypothesis) was
computed. The effect size w was defined as follows:
w ¼
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
X
i¼1
m P0i−P1ið Þ2
P0i
s
where P0i = cell frequency in the ith cell under H0
P1i = cell frequency in the ith cell under H1.
The power is then a function of the total sample size
N, the degrees of freedom, the specified significance
level, and the computed effect size w.
We also computed the correlations between all trimodal
sites and SNPs in the Qatari cohort as another measure of
association using the “cor.test” routine in R.
Testing for SNP-methylation association in the KORA
sample
The SNP-methylation association was assessed in the
KORA sample using a linear model to test for the asso-
ciation between DNA methylation (β values) and genetic
variance. Three SNPs from the vicinity of the CpG site
(within ±5 Mb around the CpG site) were obtained for
each CpG if associations were found. The covariates
used in the model included age, gender, BMI, and white
blood cell coefficients, which were estimated using the
method described by Houseman et al. [29]. Blood cell
type coefficients included monocytes, granulocytes, NK
cells, B cells, CD8+ T cells, and CD4+ T cells. The selec-
tion of the three strongest SNPs was performed iteratively
and has been described previously [25]. Briefly, selection
was performed iteratively by testing the association of each
β value for additive linear dependence on every genotyped
SNP with the window using the chosen covariates.
Once the strongest SNP (SNP1) was determined, a second
(SNP2), and third (SNP3) were selected following the same
procedure but including the previously selected SNP(s) as
additional covariates.
eQTL analysis
An online tool for annotating genetic variants (SNiPA)
[30] was used for the enrichment analysis of meQTLs that
are associated with the trimodal sites for overlap with an
expression quantitative trait locus (eQTL). SNiPA inte-
grates eQTL data from multiple sources, including the
Genotype-Tissue Expression project [31] and the seeQTL
database for human eQTLs [32].
A non-biased selection of randomized SNPs is needed
to test whether random SNPs have the same likelihood
of being linked to an eQTL gene as meQTLs that are as-
sociated with trimodal sites. In our study, the selection
of randomized SNPs was performed using the SNPsnap
Web server [33], which selects SNPs with genetic prop-
erties similar to those of a provided query list of SNPs.
Selection using this tool ensures appropriate matching
of random SNPs and avoids biasing the enrichment. The
matching is based on minor allele frequency, number of
SNPs in linkage disequilibrium (LD), distance to the
nearest gene, and gene density.
Results
Almost 1000 trimodal CpG sites are shared between the
Qatar and KORA cohorts
There was strong overall correlation of the median of all
methylation sites between the Qatari and KORA samples
(R = 0.94). The correlation plot of the two datasets is
shown in Fig. 1. Considering both the Qatari cohort and
Fig. 1 Correlation between the QMDiab study and the KORA
population study. Each point represents the median of the methylation
values for one of the 457,004 CpG sites assayed in the two cohorts
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the larger cohort KORA together, and also allowing only
5% of the subjects to have methylation values outside of
the three predetermined ranges, an overlap of 955 tri-
modal sites was found. Additional file 1: Figure S1 shows
a regional plot of the physical locations of those trimodal
sites with respect to all of the methylation sites mea-
sured by the 450 K array, showing no particular location
bias and that trimodal sites are dispersed genome-wide.
A histogram of each of these sites can be viewed in
Additional file 2: File S1.
Mendelian inheritance is observed in 99% of the cases
Within the 123 subjects from the Qatari cohort, 18 trios
were available. The 955 trimodal sites in all 18 trios were
tested for Mendelian violations. All but one of the sites
showed Mendelian agreement in all trios. Using 1000
randomisations of the subjects, we found that the average
number of sites violating Mendelian inheritance under the
null hypothesis was 23.1% ± 2.5, making the results of
study being a chance event highly unlikely (P = 1.19 × 10-6,
chi-squared test). An example of a trimodal methylation
site that follows Mendelian inheritance in different fam-
ilies having several offspring is shown in Fig. 2.
Genetic variance that is not in the immediate vicinity of
the CpG sites drives trimodality
The 955 trimodal sites were tested for associations with
genetic variants (SNPs) to identify methylation quantitative
trait loci (meQTL) using 40× whole genome sequencing
data within a +/−1 Mb window around the trimodal CpG
site. Figure 3 shows the fraction of trimodal sites that
do not have a meQTL that can explain the CpG tri-
modality as a function of window size. With increasing
window size, as a consequence of testing more SNPs,
the statistical power eventually drops below 95%, so
that no conclusion can be drawn above this distance.
Over 80% of all trimodal sites had no SNP within the
direct vicinity of the CpG site (at least 100 nt from the
boundary of the probe-binding region), and 46% of all
trimodal sites had no meQTL within 1000 nt from the
CpG site. We then checked for the presence of inser-
tions or deletions within the probe binding regions of
our 955 trimodal sites. None of the trimodal CpG sites
were affected.
Since our study did not have sufficient power to evalu-
ate window sizes larger than 5000 nt in the Qatari family
cohort, we then turned to the population based KORA
study. We found that within a 5-Mbp window in the
KORA dataset, 97% of the trimodal sites had a meQTL
association with P < 1 × 10-7 (Bonferroni 0.05/457,004
cutoff, conservatively correcting using genome-wide sig-
nificance) in that region. In addition, over 90% of these
meQTLs were found to be within the first 100 kbp of
the trimodal CpG sites. After excluding all sites for
which the trimodality could be explained by such a
meQTL, only 28 CpG sites (3%) remained. Since KORA
genotyping is array based and does not cover all existing
variants, it is likely that a meQTL was still present for
these remaining CpG sites as well (see Additional file 3:
File S2 for data on those 28 sites).
Fig. 2 An example of Mendelian inheritance at a trimodal CpG site. The histograms on the left show the distribution of the methylation of CpG
probe cg18285337 (β values) for both studies. On the right, examples of pedigrees from four families (constituting 12 father-mother-child trios) for
this CpG are given, showing strict Mendelian inheritance of methylation β value
Zaghlool et al. Clinical Epigenetics  (2016) 8:124 Page 5 of 10
Mendelian meQTLs are enriched in eQTLs
Using SNiPA [30], we investigated enrichment of the
meQTLs associated with trimodal sites for overlap with
an expression quantitative trait locus (eQTL) (excluding
the 28 trimodal sites where no strong meQTL associ-
ation was found). We found that with a LD threshold of
r2 ≥ 0.8, 46% of the queried variants had a direct effect
on regulation of gene expression through at least one
cis-eQTL. These data along with the KORA SNP associ-
ations are shown in Additional file 4: File S3.
We further tested whether random SNPs have the
same likelihood of being linked to an eQTL gene as
meQTLs that are associated with trimodal sites or not.
The method used for the selection of random SNP sets
is described in the “Methods”. A total of 1000 random
sets were generated, and only 15% ± 1.2 of the randomly
selected SNPs were also linked to an eQTL. Therefore,
there was significant enrichment in the trimodal sites
being linked to an eQTL (46%) compared to a mean of
15% in the random sets (P = 4.08 × 10-6, chi-squared
test). Further confirmation is shown in data from eight
previous eQTL studies indicating that the number of
eQTLs in all SNPs ranges between <1–19% [34], which
is in agreement with our randomization.
Trimodal CpG sites have the highest estimates of genetic
heritability
For each of our triomodal CpG sites, we looked up the
genetic heritability estimates of DNA methylation levels
provided by McRae et al. [35]. Our set of trimodal CpG
sites yielded a mean heritability of 0.80 ± 0.18. In com-
parison to their average genetic heritability of 0.199 for
all probes together, our trimodal CpG sites all fell in the
higher end of the distribution of heritability estimates.
Discussion
The similarity in DNA methylation between relatives has
been shown previously to be predominantly due to the
genetic effects [35]. On a single CpG site level, most
methylation β value profiles typically are observed to
display a mono-modal (Gaussian-like) distribution near
zero or one [36]. In contrast, only a small subset of
CpGs is multi-modal. A population-based global analysis
was designed to identify this small subset of trimodal
methylation sites from the more prevalent mono-modal
ones. Using 450 K methylation together with 40× whole
genome sequencing data from a Qatari family study, we
investigated the Mendelian inheritance of DNA methyla-
tion. We focused on DNA methylation patterns that dis-
played a replicated trimodal distribution at the population
level. As an example, Fig. 2 shows a Mendelian inherited
probe (cg18285337), whose distribution is clearly trimodal
in both the Qatari familial sample and in a validation
population sample from the KORA cohort. In the family
presented at the top of Fig. 2, the CpG site of the mother
is unmethylated while that of the father is fully methylated
at cg18285337 (both alleles). Following a Mendelian mode
of inheritance, the mother can only pass on an unmethy-
lated version of that CpG site while the father can only
transmit a methylated version, resulting in both children
displaying a hemi-methylated site. Analogously, the other
families depicted in Fig. 2 also correspond to a clear Men-
delian inheritance pattern for this site.
Overall, we identified through analysis of the Qatari
family sample and the KORA population study, a total
of 955 trimodal loci, of which 99.9% were transmitted in
a Mendelian fashion. Using whole genome sequencing
data, we excluded all sites where potential interference
of genetic variants in the observed CpG site itself could
occur and also the possibility of spurious signals from
correlation of genetic variance with the binding efficacy
of the Illumina methylation probes. Then, we carried out
a meQTL association study around the trimodal sites in
the Qatari and KORA samples. In almost all cases (97%),
methylation at these trimodal sites was strongly associ-
ated with meQTLs located within less than 1 Mb from
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Fig. 3 meQTL analysis. The red line represents cases where no SNP-CpG
association was detected at 95% power within the given window. The
black line represents cases where a SNP-CpG association was found at a
95% certainty of not falsely rejecting the null hypothesis. The actual
number of SNPs tested in the respective window was used to correct
for multiple testing (Bonferroni correction), effectively limiting this
analysis to a maximal distance of 5000 bp from the CpG site, above
which the presence of any SNP-CpG association can be neither
confirmed nor rejected with 95% certainty. The region between
0–110 bp corresponds to the probe-binding region. CpGs that
contain SNPs in this region were excluded from the analysis. For
instance, at 95% power, only 16% of the sites have a SNP within
the first 100 nucleotides from the end of the probe-binding region
(210 bp from the CpG), while 54% of the sites have a SNP within the
first 1000 nucleotides. In KORA, only genotyped SNPs are available;
hence, a windowed approach was not possible. However, the KORA
study is sufficiently powered to detect any SNP association inside a
window of 5 Mb, revealing that 97% of the sites have a SNP-CpG
association in that region. The dashed line represents a likely
extrapolation of the pattern that would be expected in a similar
windowed analysis in KORA
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the CpG site; in about half of the cases, these SNPs (or a
strong proxy—r2 > 0.8) were also eQTLs [30]. Although
the chances of finding a single case of Mendelian inher-
itance by chance are relatively high (77%), the presence
of underlying SNP associations for 97% of the CpG sites
confirms the genetic basis of the observed Mendelian in-
heritance pattern. The likelihood of finding a meQTL
association obviously depends on the window size, and
limiting the search to cis-acting meQTLs cannot rule
out the possibility of undiscovered trans-acting meQTLs
anywhere in the genome that could explain the remaining
3% of trimodal CpG sites.
The role of CpG methylation in the regulation of gene
expression has been well established, and several studies
have shown that genetic variations are linked to quanti-
tative changes in methylation [37–39]. Many meQTLs
are also reported to be associated with changes in gene
expression (eQTLs) [40], but it remains unclear whether
methylation changes are a cause or consequence of al-
tered gene expression. Genetic variants are suggested
to perform a regulatory role coordinating all of the mo-
lecular changes, possibly through mechanisms leading to
variations in transcription factor binding, modification of
enzymes and their cofactors, or non-coding RNAs [39].
The association of changes in transcription factor binding
with changes in DNA methylation contributes to the regu-
latory role of DNA methylation in the context of gene
regulation.
Although the concept of CpG heritability has been
generally addressed previously [35], to the best of our
knowledge, the heritability patterns of methylation con-
strained to globally trimodal sites has not been explored.
Previous studies identified a link between CpG methyla-
tion and genetic variation at proximal loci (cis-meQTLs)
[39], but the study designs did not allow the investiga-
tion of inheritance. Trimodal sites are the most clearly
heritable sites and represent the maximum level of herit-
ability in methylation. Based on previously published
data, our trimodal CpG sites have a mean heritability of
0.80 ± 0.18 [35]. Therefore, having the highest genetic
heritability estimates can be attributable to the property
of trimodality of these particular CpG sites. These CpG
sites are more likely to also associate with meQTLs.
Why trimodality is limited to particular CpG sites
while other CpG sites within the same neighbourhood
or vicinity do not follow the same pattern is an intriguing
question. The pattern is clearly visible in the human
leukocyte antigen (HLA) region, which for its medical
interest has high CpG coverage on the Illumina array. It
contains 17 trimodal CpG sites that are spread out among
more than 4500 other CpG sites, none of which are trimo-
dal. The 3D structure of DNA packaging play a role
through interactions between DNA loops. Because CpG
sites are not physically situated in a linear space, this may
allow distant CpG sites to actually become neighboring
sites and vice versa.
We show that trimodality is not restricted to certain
chromosomes or genes, and Additional file 1: Figure S1
further confirms the absence of any global bias in trimodal
site density in the panel of sites tested by the Illumina
HumanMethylation 450 K array.
In an effort to understand whether trimodality is
common to specific classes of CpG sites, we tested for
enrichment in CpG sites designated as regulatory ele-
ments, such as promoter or enhancers, differentially
methylated regions, or cell type-specific regions, according
to the Illumina manifest. In the trimodal sites, we ob-
served significant depletion of regulatory elements (e.g.,
5’UTR, 1st exon, proximity to transcription start sites
TSS200 and TSS1500), promoter associated, CpG islands,
and an enrichment in gene body and 3’UTR (data not
shown). Further experiments are needed to explain this
observed depletion; however, that is beyond the scope of
this particular study.
Of interest, the eQTLs in the HLA region are linked
with different meQTLs associated with 17 trimodal sites
in chromosome 6 (Fig. 4). We focused on the major
histocompatibility complex (MHC) region because it is
known to have the highest estimates of genetic heritabil-
ity compared to the whole genome [35]. This locus en-
compasses one of the most gene-dense regions of the
human genome and is why it is deeply probed. MHC
controls a major part of the innate and adaptive immune
systems and is associated with many diseases [41]. Vari-
ants in the HLA region can have a cis effect on regulation
of gene expression through cis-eQTLs and transcription,
impacting both the expression level of HLA genes and
methylation by giving rise to trimodal sites in these spe-
cific locations. This small subset of trimodal sites observed
here is clearly due to strong genetic variations as this ef-
fect does not spill over to the entire set of CpG sites in the
same region.
We can only speculate on the underlying mechanisms
yielding methylation-genotype dependence. A genetic
variant in a CpG site itself would lead to a trimodal
distribution with a Mendelian pattern of inheritance.
Unlike other studies [35] that use public data (i e., 1000
Genomes Project) where not all genetic sequence variation
in the probe regions has been detected, we excluded these
“trivial” cases from this study using our available 40×
whole genome sequencing data that is also specific to our
particular cohort under study. Changes in DNA methyla-
tion may play a role in biological feedback of regulation or
in maintaining methylation between the observed trimodal
CpG site and other CpG sites that are directly impacted
by a genetic variant. Methylation at a particular site
usually spreads out or is maintained by local methyla-
tion processes. A trimodal CpG site can be impacted by
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neighboring CpG sites depending on their methylation
states. The first potential process leading to a genetically
driven methylation site can occur when these neighboring
CpG sites are affected by a SNP, resulting in the observed
genotype-dependent effect being transmitted to the trimo-
dal CpG sites as well. Hence, the observed trimodality is
driven by a variant that is distal but located in cis to the
CpG site. The second process that may lead to a genetic-
ally driven methylation site can be due to the mutation
changing gene expression activity (eQTL) which in turn,
by feedback, reflects on the methylation readout. This
scenario is less likely than the third process that may lead
to a genetically driven methylation site. Most likely, the
genetically driven change occurs in a methylation site that
resides in a regulatory region resulting in different levels
of gene expression. It is also worth noting that since the
majority of meQTLs (which also happen to be “coinci-
dent” with eQTLs) are actually close in distance (within
100 kbp) to the trimodal CpG sites, it is also still possible
that these genetic variants and trimodal CpG sites both
reside on the same haplotype only by chance. So the asso-
ciation may actually be due to the haplotype with the vari-
ant of the SNP being close to the CpG site and not really
having a role on gene expression.
Fig. 5 Potential processes leading to a genetically driven methylation site. Three potential processes can lead to an association of a genetic
variant and a trimodal distribution of CpG methylation: (1) “Spillover from a neighboring CpG site” that is deleted by a SNP by processes of local
methylation maintenance, (2) SNP-induced changes in gene expression activity may have a feedback effect on DNA methylation due to differences in
the translation machinery that leaves methylation marks on the DNA, and (3) SNP-induced changes in gene function may induce different levels of
gene expression that are implemented by changes in promoter gene methylation
Fig. 4 HLA Region. The 17 trimodal CpG sites found in the HLA region are shown below the eQTL SNPS (red stars). The red lines shown indicate
all CpG sites in the HLA locus that are assayed by the methylation array (4754 sites). All trimodal sites in the region were strongly associated with
at least one SNP (KORA). In most cases, the same SNP was also an eQTL gene. The red stars indicate the associated eQTL SNPs (LD > 0.8 between
the SNP and the reported eQTL). The trimodal sites all had a correlation of >0.92 with the SNP while the remaining CpGs in the region had a
correlation less than 0.2
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Conclusions
In summary, three plausible mechanisms could lead to
association between a genetic variant and a trimodal
CpG site. The first possibility is a spillover of trimodal
methylation from a nearby CpG that is modified by a
genetic variant in the site (e.g., by a CpG-to-TpG variant)
by global DNA methylation-maintaining proteins [42].
The second is a feedback mechanism in which a genetic
variant modifies gene expression, and the resulting chan-
ged translation activity then leaves a modified trace in the
DNA methylation level [43]. The third is a feedback mech-
anism in which a genetic variant modifies methylation in a
promoter region inducing changes in gene expression.
These potential processes are summarized in Fig. 5. In
conclusion, we observed and confirmed Mendelian inher-
itance of CpG methylation, but almost all trimodal CpG
sites are driven by genetic variance.
Additional files
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